Increased Demand Drives Queensland Compound Library Expansion
News Jun 10, 2010
Queensland Compound Library (QCL) has announced the acquisition and installment of a fourth comPOUND® sample store from TTP LabTech Ltd.
The purchasing of a fourth sample store, to integrate with their three existing comPOUND sample stores and comPANION unit, comes two years after QCL became operational and one year after the third store was added. This new purchase reflects the on-going success of QCL and the increased demand for compound management and logistics services now considered essential by the Australian life sciences industry, QCL said.
TTP LabTech’s comPOUND sample store is a modular system, where individual units can be linked in parallel in response to growing library size. The self-contained modules each have their own cherry picking facility and can provide sample storage at a user defined temperature between ambient and -20°C depending on the user’s requirements.
The comPANION arrayer unit connects comPOUND stores to provide remote delivery or storage of individual microtubes from each of the sample stores.
Dr David Camp of QCL commented, ‘More than 300,000 compounds have been deposited by QCL members since mid 2008 which has necessitated the purchase of our fourth comPOUND sample store. Fortunately, the system is easily expanded to cater for increased demand. This has been the second comPOUND to be added since the QCL was established. The installation went seamlessly with full integration of the new module achieved mid-way through the second day. Sample processing was up and running by the third day, breaking the previous record set by the 3rd store which is not only good for the QCL but also for its members.”
Dr Camp went on saying, “Our members are from different organizations with vastly different needs. The QCL must cater for everything from open access samples to very limited access samples. The comPOUND sample store and our in-house checks allow us to use samples as intended.’
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Big-Data Analysis Points Toward New Drug Discovery MethodNews
A research team has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018